BiotechTube

Metyrosine + Placebo

Phase 2Terminated
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Velo-cardio-facial Syndrome

Conditions

Velo-cardio-facial Syndrome, Psychosis

Trial Timeline

Jun 1, 2010 → Sep 1, 2011

NCT ID
NCT01127503

About Metyrosine + Placebo

Metyrosine + Placebo is a phase 2 stage product being developed by Bausch Health for Velo-cardio-facial Syndrome. The current trial status is terminated. This product is registered under clinical trial identifier NCT01127503. Target conditions include Velo-cardio-facial Syndrome, Psychosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01127503Phase 2Terminated

Other Products from Bausch Health

nabiloneApproved
80
High dose budesonide rectal foam + Low dose budesonide rectal foam + Matching placebo rectal foamApproved
80
benzoyl peroxide wash + Tretinoin gelApproved
80
Adapalene Gel + Tretinoin GelApproved
80
Omeprazole/sodium bicarbonateApproved
80